Home » UK’s MHRA Adds Addiction Warning to OTC Codeine Products
UK’s MHRA Adds Addiction Warning to OTC Codeine Products
September 17, 2009
Drugmakers marketing OTC drugs containing codeine and dihydrocodeine should add prominent warnings in labeling and patient information leaflets about the risk of addiction and the importance of taking the medicines no longer than three days, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor